View in EDS HTML Full Text PDF Full Text

Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema.

Saved in:
Bibliographic Details
Title: Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema.
Authors: Andresen, Irmgard1 (AUTHOR) irmgard.andresen@takeda.com, Khutoryansky, Natalie2 (AUTHOR), Feeny, Sarah L.2 (AUTHOR), Dangel, Alissa3 (AUTHOR)
Source: Drugs in R&D. Mar2026, Vol. 26 Issue 1, p31-33. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:11745886
DOI:10.1007/s40268-026-00539-8